Romesh Subramanian
Equibles does not estimate personal net worth.
About Romesh Subramanian
Dyne Therapeutics, Inc. reported in an 8-K filed June 2, 2021 that Romesh Subramanian resigned as Chief Scientific Officer, effective June 2, 2021. The proxy statement of Dyne Therapeutics, Inc. reports total compensation of $4,370,975 for Romesh Subramanian in fiscal 2020, including a base salary of $371,875. Disclosed compensation is on record for 2 fiscal years.
“On May 27, 2021, Romesh Subramanian, Ph.D., the Chief Scientific Officer of Dyne Therapeutics, Inc. (the “Company”), notified the Company that he planned to resign his employment with the Company effective June 2, 2021 (the “Resignation Date”).”
Affiliation history
-
Dyne Therapeutics, Inc. (DYN)
Proxy statement
Start not stated–2021-06-02
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Dyne Therapeutics, Inc. (DYN) | Chief Scientific Officer | $371,875 | $4,370,975 |
| 2019 | Dyne Therapeutics, Inc. (DYN) | Chief Scientific Officer | $350,002 | $411,660 |